FDA Inspection 1269430 — Biohaven Pharmaceuticals, Inc
The FDA completed an inspection of Biohaven Pharmaceuticals, Inc on Apr 24, 2025 in New Haven, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 24, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New Haven, CT (United States)
Additional details
Sponsor, Contract Research Organization